Pharmacometabolomics by NMR in Oncology: A Systematic Review

Pharmacometabolomics (PMx) studies aim to predict individual differences in treatment response and in the development of adverse effects associated with specific drug treatments. Overall, these studies inform us about how individuals will respond to a drug treatment based on their metabolic profiles...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceuticals (Basel, Switzerland) Vol. 14; no. 10; p. 1015
Main Authors: Gómez-Cebrián, Nuria, Vázquez Ferreiro, Pedro, Carrera Hueso, Francisco Javier, Poveda Andrés, José Luis, Puchades-Carrasco, Leonor, Pineda-Lucena, Antonio
Format: Journal Article
Language:English
Published: Basel MDPI AG 02-10-2021
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Pharmacometabolomics (PMx) studies aim to predict individual differences in treatment response and in the development of adverse effects associated with specific drug treatments. Overall, these studies inform us about how individuals will respond to a drug treatment based on their metabolic profiles obtained before, during, or after the therapeutic intervention. In the era of precision medicine, metabolic profiles hold great potential to guide patient selection and stratification in clinical trials, with a focus on improving drug efficacy and safety. Metabolomics is closely related to the phenotype as alterations in metabolism reflect changes in the preceding cascade of genomics, transcriptomics, and proteomics changes, thus providing a significant advance over other omics approaches. Nuclear Magnetic Resonance (NMR) is one of the most widely used analytical platforms in metabolomics studies. In fact, since the introduction of PMx studies in 2006, the number of NMR-based PMx studies has been continuously growing and has provided novel insights into the specific metabolic changes associated with different mechanisms of action and/or toxic effects. This review presents an up-to-date summary of NMR-based PMx studies performed over the last 10 years. Our main objective is to discuss the experimental approaches used for the characterization of the metabolic changes associated with specific therapeutic interventions, the most relevant results obtained so far, and some of the remaining challenges in this area.
AbstractList Pharmacometabolomics (PMx) studies aim to predict individual differences in treatment response and in the development of adverse effects associated with specific drug treatments. Overall, these studies inform us about how individuals will respond to a drug treatment based on their metabolic profiles obtained before, during, or after the therapeutic intervention. In the era of precision medicine, metabolic profiles hold great potential to guide patient selection and stratification in clinical trials, with a focus on improving drug efficacy and safety. Metabolomics is closely related to the phenotype as alterations in metabolism reflect changes in the preceding cascade of genomics, transcriptomics, and proteomics changes, thus providing a significant advance over other omics approaches. Nuclear Magnetic Resonance (NMR) is one of the most widely used analytical platforms in metabolomics studies. In fact, since the introduction of PMx studies in 2006, the number of NMR-based PMx studies has been continuously growing and has provided novel insights into the specific metabolic changes associated with different mechanisms of action and/or toxic effects. This review presents an up-to-date summary of NMR-based PMx studies performed over the last 10 years. Our main objective is to discuss the experimental approaches used for the characterization of the metabolic changes associated with specific therapeutic interventions, the most relevant results obtained so far, and some of the remaining challenges in this area.
Author Puchades-Carrasco, Leonor
Vázquez Ferreiro, Pedro
Pineda-Lucena, Antonio
Gómez-Cebrián, Nuria
Poveda Andrés, José Luis
Carrera Hueso, Francisco Javier
AuthorAffiliation 1 Drug Discovery Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain; nuria_gomez@iislafe.es
5 Molecular Therapeutics Program, Centro de Investigación Médica Aplicada, 31008 Navarra, Spain
2 Ophthalmology Department, Hospital Virxen da Xunqueria, 15270 A Coruña, Spain; pedro.vazquez.ferreiro@sergas.es
4 Pharmacy Department, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain; poveda_joseand@gva.es
3 Pharmacy Department, Hospital Universitario La Plana, 12004 Castellón, Spain; carrera_fra@gva.es
AuthorAffiliation_xml – name: 2 Ophthalmology Department, Hospital Virxen da Xunqueria, 15270 A Coruña, Spain; pedro.vazquez.ferreiro@sergas.es
– name: 5 Molecular Therapeutics Program, Centro de Investigación Médica Aplicada, 31008 Navarra, Spain
– name: 4 Pharmacy Department, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain; poveda_joseand@gva.es
– name: 1 Drug Discovery Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain; nuria_gomez@iislafe.es
– name: 3 Pharmacy Department, Hospital Universitario La Plana, 12004 Castellón, Spain; carrera_fra@gva.es
Author_xml – sequence: 1
  givenname: Nuria
  orcidid: 0000-0001-5604-9223
  surname: Gómez-Cebrián
  fullname: Gómez-Cebrián, Nuria
– sequence: 2
  givenname: Pedro
  surname: Vázquez Ferreiro
  fullname: Vázquez Ferreiro, Pedro
– sequence: 3
  givenname: Francisco Javier
  surname: Carrera Hueso
  fullname: Carrera Hueso, Francisco Javier
– sequence: 4
  givenname: José Luis
  surname: Poveda Andrés
  fullname: Poveda Andrés, José Luis
– sequence: 5
  givenname: Leonor
  orcidid: 0000-0003-0340-7458
  surname: Puchades-Carrasco
  fullname: Puchades-Carrasco, Leonor
– sequence: 6
  givenname: Antonio
  orcidid: 0000-0002-3532-8781
  surname: Pineda-Lucena
  fullname: Pineda-Lucena, Antonio
BookMark eNpdkV1rFDEUhoNU7Ife-AsGvBFhNV8nyYgIpfhRqFaqXockc7I7y8xkm8xW9t-bdotayUXCycPDe845JgdTmpCQ54y-FqKlbzYrJhmtBx6RIya5XBgu9cE_70NyXMqaUtCVfEIOhVSGcdEekXffVi6PLqQRZ-fTkMY-lMbvmq9frpp-ai6nUIvL3dvmtPm-KzOObu5Dc4U3Pf56Sh5HNxR8dn-fkJ8fP_w4-7y4uPx0fnZ6sQhStvOiM4EpEcCzIBTjDgKNGqKQNLqgaAughDGKAfouKqOxkwYFcFAmKk9BnJDzvbdLbm03uR9d3tnkentXSHlpXa6xBrQdalDaAOVdbRWVcVF7HcG50HkXfHW937s2Wz9iF3CasxseSB_-TP3KLtONNSBaDrwKXt4LcrreYpnt2JeAw-AmTNtiORipWyU0q-iL_9B12uapjuqOkgo4vRW-2lMhp1Iyxj9hGLW3C7Z_Fyx-A-ivlyk
CitedBy_id crossref_primary_10_3390_ijms24043291
crossref_primary_10_1089_omi_2022_0097
crossref_primary_10_3389_fcimb_2022_882661
Cites_doi 10.1016/j.cmet.2013.08.002
10.3390/molecules26082266
10.1002/cpbi.11
10.1373/clinchem.2018.287045
10.1007/s00216-015-8565-x
10.1038/ijo.2015.40
10.3389/fbioe.2015.00023
10.1038/nmeth.3968
10.1002/wsbm.1199
10.3390/metabo11010045
10.1111/bph.12749
10.1177/0004563213497929
10.2217/pgs.10.157
10.1007/s11306-016-1055-0
10.3390/metabo10040129
10.1093/nar/gkm957
10.1038/s41430-018-0386-5
10.1016/j.clinbiochem.2016.10.016
10.1016/j.nbt.2019.04.004
10.1016/j.jchromb.2014.08.011
10.1016/j.cell.2008.08.026
10.1093/nar/gkl923
10.3389/fneur.2017.00459
10.18632/oncotarget.18784
10.17226/13059
10.1111/cas.14443
10.1016/j.ccell.2017.06.004
10.1007/978-3-319-47656-8_8
10.1007/s11095-006-0025-z
10.1371/journal.ppat.1009243
10.3390/metabo9070123
10.2147/COPD.S173264
10.1186/1471-2229-11-104
10.1021/ac060209g
10.1016/S1471-4914(01)01986-4
10.1007/s11523-011-0174-9
10.1021/ac0519312
10.3109/01480545.2014.981753
10.1016/j.ekir.2019.09.010
10.1158/1078-0432.CCR-16-1153
10.1038/nature04648
10.1093/nar/gks1065
10.1016/j.jpba.2017.08.018
10.1136/jnnp.63.6.754
10.1007/s11306-018-1452-7
10.1007/s40256-019-00364-2
10.1186/s12885-021-08137-4
10.1002/ijc.28597
10.1006/jmra.1995.1047
10.1002/cpt.134
10.1016/j.archoralbio.2018.10.023
10.1093/bioinformatics/btl074
10.1007/s00216-012-6039-y
10.1021/acsomega.8b02714
10.1021/acs.jproteome.5b01032
10.1093/nar/gkv380
10.1016/j.atherosclerosis.2018.04.008
10.1007/s10549-018-4862-3
10.1038/nrm.2016.25
10.2147/COPD.S152134
10.1002/mnfr.201000458
10.1002/art.41622
10.1371/journal.pcbi.1002817
10.1177/0897190012448309
10.1093/nar/gkv1042
10.1513/AnnalsATS.201409-415OC
10.1186/s12967-020-02231-0
10.1038/s41598-019-38823-0
10.20944/preprints202101.0521.v1
10.1016/j.chemolab.2013.01.006
10.1002/art.37921
10.1161/CIRCULATIONAHA.109.914820
10.21037/gs-20-202
10.1063/1.1716296
10.1016/j.ejps.2018.03.011
10.1038/nrg2751
10.1056/NEJMra032424
10.1016/j.jpba.2016.09.034
10.1021/acs.jproteome.8b00567
10.1128/MCB.22.15.5575-5584.2002
10.1097/QAD.0000000000001730
10.1021/ac402390q
10.1007/s11306-019-1576-4
10.1016/j.trac.2011.04.019
10.1016/j.molonc.2012.10.003
10.1021/ac00101a004
10.3389/fphar.2019.01107
10.3390/cancers12123574
10.1007/s00726-017-2419-0
10.1007/s11306-017-1178-y
10.1007/s11306-018-1321-4
10.1046/j.0306-5251.2001.01498.x
10.1161/CIRCGENETICS.116.001564
10.1111/cts.12401
10.1203/00006450-199812000-00013
10.3892/etm.2012.567
10.1007/s11065-007-9021-2
10.1016/j.jneuroim.2020.577385
10.1016/j.bbrc.2003.09.092
10.1016/S0003-2670(03)00060-6
10.1007/s12264-013-1316-0
10.3389/fbioe.2015.00038
10.1073/pnas.0904489106
10.3390/metabo10050202
10.1021/acs.jproteome.7b00859
10.1038/embor.2013.5
10.1038/nprot.2007.376
10.1016/j.trre.2014.03.002
10.1146/annurev-biochem-061516-044952
10.1097/CCM.0b013e31822571ce
10.1016/j.jmr.2006.10.014
10.1158/1078-0432.CCR-12-2917
10.1016/j.rapm.2006.11.009
10.1021/pr200200y
10.1002/cmr.a.20223
10.1161/HYPERTENSIONAHA.117.09819
10.1038/nbt0208-162
10.3390/molecules26092573
10.1634/theoncologist.2010-0035
10.1371/journal.pone.0138537
10.1021/acs.jproteome.9b00316
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/ph14101015
DatabaseName CrossRef
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
ProQuest Central Student
Research Library Prep
ProQuest Research Library
Research Library (Corporate)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1424-8247
ExternalDocumentID oai_doaj_org_article_de75678502d141e68af7b7f5aacdbacb
10_3390_ph14101015
GroupedDBID ---
2WC
3V.
53G
5VS
8G5
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ADBBV
AEAQA
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
EBD
ESX
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MK0
MODMG
M~E
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RPM
TUS
7XB
8FK
COVID
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c449t-d8c163c5b1c3612a5c0f75f340fac609556388615ebdf687ed48e352568f6b053
IEDL.DBID RPM
ISSN 1424-8247
IngestDate Tue Oct 22 15:12:24 EDT 2024
Tue Sep 17 21:24:28 EDT 2024
Fri Oct 25 06:58:11 EDT 2024
Sat Nov 09 15:46:08 EST 2024
Fri Nov 22 02:48:08 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c449t-d8c163c5b1c3612a5c0f75f340fac609556388615ebdf687ed48e352568f6b053
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0001-5604-9223
0000-0002-3532-8781
0000-0003-0340-7458
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539252/
PMID 34681239
PQID 2584465202
PQPubID 2032350
ParticipantIDs doaj_primary_oai_doaj_org_article_de75678502d141e68af7b7f5aacdbacb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8539252
proquest_miscellaneous_2584796371
proquest_journals_2584465202
crossref_primary_10_3390_ph14101015
PublicationCentury 2000
PublicationDate 20211002
PublicationDateYYYYMMDD 2021-10-02
PublicationDate_xml – month: 10
  year: 2021
  text: 20211002
  day: 2
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Pharmaceuticals (Basel, Switzerland)
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Bhinderwala (ref_61) 2018; 17
ref_92
Hendriks (ref_126) 2011; 30
Ventola (ref_8) 2013; 38
Boguszewicz (ref_101) 2019; 15
ref_13
Jobard (ref_51) 2017; 8
Gibney (ref_67) 2011; 55
Pagliarulo (ref_2) 2002; 4
Gu (ref_35) 2020; 111
Nicholson (ref_19) 2011; 12
Goossens (ref_77) 2016; 15
Weljie (ref_87) 2006; 78
Lindon (ref_96) 2006; 23
Craig (ref_83) 2006; 78
Ricoult (ref_110) 2013; 14
Ghini (ref_32) 2019; 52
Nguyen (ref_56) 2007; 184
Ni (ref_10) 2013; 5
Jiang (ref_46) 2018; 17
Vuckovic (ref_124) 2012; 403
Huo (ref_60) 2014; 969
ref_24
ref_22
Debik (ref_48) 2019; 18
Lewis (ref_16) 2014; 3
ref_21
Wang (ref_73) 2017; 12
Moyle (ref_120) 2007; 17
Wishart (ref_84) 2007; 35
Lindon (ref_14) 2006; 440
Wilkinson (ref_3) 2005; 352
Zhou (ref_119) 1997; 63
Domingo (ref_47) 2018; 273
ref_72
Weinshilboum (ref_17) 2015; 98
Nicholson (ref_55) 1995; 67
Schmedders (ref_12) 2003; 3
Boehm (ref_121) 1998; 44
Wei (ref_76) 2020; 9
Meiboom (ref_54) 1958; 29
Eppinga (ref_107) 2017; 10
Beckonert (ref_97) 2003; 490
Cano (ref_25) 2011; 10
Ara (ref_93) 2015; 3
Raykov (ref_122) 2014; 134
Madhu (ref_29) 2016; 12
Signoriello (ref_69) 2020; 348
Chaudhari (ref_28) 2017; 49
Daly (ref_5) 2010; 11
Kim (ref_79) 2013; 85
Viant (ref_59) 2003; 310
Emwas (ref_82) 2018; 14
Sun (ref_94) 2018; 171
Jacob (ref_64) 2017; 13
Ma (ref_9) 2012; 25
Khalid (ref_75) 2019; 9
Lamming (ref_111) 2013; 18
Gooding (ref_40) 2020; 5
Yu (ref_117) 2013; 29
Holmes (ref_15) 2008; 134
Huang (ref_116) 2007; 32
Alonso (ref_81) 2015; 3
Park (ref_39) 2011; 39
Sud (ref_95) 2016; 44
Miccheli (ref_80) 2015; 39
Lu (ref_125) 2017; 86
ref_53
ref_52
Kirwan (ref_129) 2018; 64
Roden (ref_6) 2011; 123
Clayton (ref_18) 2009; 106
Amin (ref_74) 2018; 117
Hart (ref_109) 2017; 23
Sousa (ref_65) 2013; 122
Shukla (ref_123) 2017; 32
Martinez (ref_44) 2017; 70
Tan (ref_68) 2018; 13
Gebregiworgis (ref_26) 2018; 14
Xia (ref_105) 2016; 55
Lever (ref_66) 2016; 13
Singh (ref_98) 2017; 132
Murgia (ref_50) 2017; 8
Ulrich (ref_89) 2008; 36
Delanghe (ref_128) 2016; 49
Beckonert (ref_31) 2007; 2
Puskarich (ref_38) 2015; 12
Artacho (ref_34) 2021; 73
Johnson (ref_30) 2016; 17
Kapoor (ref_42) 2013; 65
Hwang (ref_57) 1995; 112
ref_63
Haug (ref_91) 2020; 48
ref_62
Trevino (ref_103) 2006; 22
Spear (ref_1) 2001; 7
Xia (ref_88) 2017; 965
Peng (ref_112) 2002; 22
Wang (ref_71) 2012; 4
Chashmniam (ref_99) 2019; 73
Wishart (ref_85) 2013; 41
Mckay (ref_58) 2011; 38
Romano (ref_27) 2019; 97
ref_36
Pirmohamed (ref_4) 2001; 52
ref_33
Lecumberri (ref_43) 2013; 19
Moschetta (ref_115) 2014; 171
Pacheco (ref_45) 2018; 32
Boekhout (ref_108) 2011; 16
Amin (ref_70) 2017; 146
ref_37
Kaplan (ref_114) 2014; 28
Cai (ref_100) 2016; 9
Botticelli (ref_23) 2020; 18
ref_106
Chiang (ref_49) 2019; 10
Yin (ref_127) 2015; 407
Yamada (ref_90) 2019; 4
Everett (ref_20) 2013; 50
Nebert (ref_11) 2003; 3
ref_102
Xia (ref_104) 2015; 43
Farshid (ref_118) 2015; 38
Cui (ref_86) 2008; 26
Wei (ref_41) 2013; 7
Bawadikji (ref_78) 2020; 20
ref_7
Soefje (ref_113) 2011; 6
References_xml – volume: 18
  start-page: 465
  year: 2013
  ident: ref_111
  article-title: A Central Role for MTOR in Lipid Homeostasis
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2013.08.002
  contributor:
    fullname: Lamming
– ident: ref_24
  doi: 10.3390/molecules26082266
– volume: 4
  start-page: 101
  year: 2002
  ident: ref_2
  article-title: Role of Genetic and Expression Profiling in Pharmacogenomics: The Changing Face of Patient Management
  publication-title: Curr. Issues Mol. Biol.
  contributor:
    fullname: Pagliarulo
– volume: 55
  start-page: 1
  year: 2016
  ident: ref_105
  article-title: Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis
  publication-title: Curr. Protoc. Bioinform.
  doi: 10.1002/cpbi.11
  contributor:
    fullname: Xia
– volume: 64
  start-page: 1158
  year: 2018
  ident: ref_129
  article-title: Preanalytical Processing and Biobanking Procedures of Biological Samples for Metabolomics Research: A White Paper, Community Perspective (for “Precision Medicine and Pharmacometabolomics Task Group”-The Metabolomics Society Initiative)
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2018.287045
  contributor:
    fullname: Kirwan
– volume: 407
  start-page: 4879
  year: 2015
  ident: ref_127
  article-title: Effects of Pre-Analytical Processes on Blood Samples Used in Metabolomics Studies
  publication-title: Anal. Bioanal. Chem.
  doi: 10.1007/s00216-015-8565-x
  contributor:
    fullname: Yin
– volume: 39
  start-page: 1118
  year: 2015
  ident: ref_80
  article-title: Urinary (1)H-NMR-Based Metabolic Profiling of Children with NAFLD Undergoing VSL#3 Treatment
  publication-title: Int. J. Obes.
  doi: 10.1038/ijo.2015.40
  contributor:
    fullname: Miccheli
– volume: 3
  start-page: 23
  year: 2015
  ident: ref_81
  article-title: Analytical Methods in Untargeted Metabolomics: State of the Art in 2015
  publication-title: Front. Bioeng. Biotechnol.
  doi: 10.3389/fbioe.2015.00023
  contributor:
    fullname: Alonso
– volume: 13
  start-page: 703
  year: 2016
  ident: ref_66
  article-title: Model Selection and Overfitting
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3968
  contributor:
    fullname: Lever
– volume: 5
  start-page: 1
  year: 2013
  ident: ref_10
  article-title: Pharmacogenomics Discovery and Implementation in Genome-Wide Association Studies Era
  publication-title: Wiley Interdiscip. Rev. Syst. Biol. Med.
  doi: 10.1002/wsbm.1199
  contributor:
    fullname: Ni
– ident: ref_37
  doi: 10.3390/metabo11010045
– volume: 171
  start-page: 3801
  year: 2014
  ident: ref_115
  article-title: Therapeutic Targeting of the MTOR-Signalling Pathway in Cancer: Benefits and Limitations
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/bph.12749
  contributor:
    fullname: Moschetta
– volume: 50
  start-page: 523
  year: 2013
  ident: ref_20
  article-title: Pharmacometabonomics and Personalized Medicine
  publication-title: Ann. Clin. Biochem.
  doi: 10.1177/0004563213497929
  contributor:
    fullname: Everett
– volume: 12
  start-page: 103
  year: 2011
  ident: ref_19
  article-title: Pharmacometabonomics as an Effector for Personalized Medicine
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs.10.157
  contributor:
    fullname: Nicholson
– volume: 12
  start-page: 120
  year: 2016
  ident: ref_29
  article-title: Response of Degarelix Treatment in Human Prostate Cancer Monitored by HR-MAS 1H NMR Spectroscopy
  publication-title: Metabolomics
  doi: 10.1007/s11306-016-1055-0
  contributor:
    fullname: Madhu
– ident: ref_13
  doi: 10.3390/metabo10040129
– volume: 36
  start-page: D402
  year: 2008
  ident: ref_89
  article-title: BioMagResBank
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkm957
  contributor:
    fullname: Ulrich
– volume: 73
  start-page: 1224
  year: 2019
  ident: ref_99
  article-title: A Pilot Study of the Effect of Phospholipid Curcumin on Serum Metabolomic Profile in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
  publication-title: Eur. J. Clin. Nutr.
  doi: 10.1038/s41430-018-0386-5
  contributor:
    fullname: Chashmniam
– volume: 49
  start-page: 1346
  year: 2016
  ident: ref_128
  article-title: Preanalytics in Urinalysis
  publication-title: Clin. Biochem.
  doi: 10.1016/j.clinbiochem.2016.10.016
  contributor:
    fullname: Delanghe
– volume: 52
  start-page: 25
  year: 2019
  ident: ref_32
  article-title: NMR for Sample Quality Assessment in Metabolomics
  publication-title: New Biotechnol.
  doi: 10.1016/j.nbt.2019.04.004
  contributor:
    fullname: Ghini
– volume: 969
  start-page: 109
  year: 2014
  ident: ref_60
  article-title: An Effective Assessment of Valproate Sodium-Induced Hepatotoxicity with UPLC-MS and (1)HNMR-Based Metabonomics Approach
  publication-title: J. Chromatogr. B Anal. Technol. Biomed. Life Sci.
  doi: 10.1016/j.jchromb.2014.08.011
  contributor:
    fullname: Huo
– volume: 134
  start-page: 714
  year: 2008
  ident: ref_15
  article-title: Metabolic Phenotyping in Health and Disease
  publication-title: Cell
  doi: 10.1016/j.cell.2008.08.026
  contributor:
    fullname: Holmes
– volume: 35
  start-page: D521
  year: 2007
  ident: ref_84
  article-title: HMDB: The Human Metabolome Database
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkl923
  contributor:
    fullname: Wishart
– volume: 8
  start-page: 459
  year: 2017
  ident: ref_50
  article-title: Metabolomics as a Tool for the Characterization of Drug-Resistant Epilepsy
  publication-title: Front. Neurol.
  doi: 10.3389/fneur.2017.00459
  contributor:
    fullname: Murgia
– volume: 8
  start-page: 83570
  year: 2017
  ident: ref_51
  article-title: Longitudinal Serum Metabolomics Evaluation of Trastuzumab and Everolimus Combination as Pre-Operative Treatment for HER-2 Positive Breast Cancer Patients
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.18784
  contributor:
    fullname: Jobard
– ident: ref_22
  doi: 10.17226/13059
– volume: 111
  start-page: 3195
  year: 2020
  ident: ref_35
  article-title: Nuclear Magnetic Resonance-Based Tissue Metabolomic Analysis Clarifies Molecular Mechanisms of Gastric Carcinogenesis
  publication-title: Cancer Sci.
  doi: 10.1111/cas.14443
  contributor:
    fullname: Gu
– volume: 32
  start-page: 71
  year: 2017
  ident: ref_123
  article-title: MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.06.004
  contributor:
    fullname: Shukla
– volume: 965
  start-page: 191
  year: 2017
  ident: ref_88
  article-title: Computational Strategies for Biological Interpretation of Metabolomics Data
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-3-319-47656-8_8
  contributor:
    fullname: Xia
– volume: 23
  start-page: 1075
  year: 2006
  ident: ref_96
  article-title: Metabonomics Techniques and Applications to Pharmaceutical Research & Development
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-006-0025-z
  contributor:
    fullname: Lindon
– ident: ref_53
  doi: 10.1371/journal.ppat.1009243
– ident: ref_21
  doi: 10.3390/metabo9070123
– volume: 13
  start-page: 2985
  year: 2018
  ident: ref_68
  article-title: 1H-NMR-Based Metabolic Profiling of Healthy Individuals and High-Resolution CT-Classified Phenotypes of COPD with Treatment of Tiotropium Bromide
  publication-title: Int. J. Chronic Obstruct. Pulmon. Dis.
  doi: 10.2147/COPD.S173264
  contributor:
    fullname: Tan
– ident: ref_92
  doi: 10.1186/1471-2229-11-104
– volume: 78
  start-page: 4430
  year: 2006
  ident: ref_87
  article-title: Targeted Profiling: Quantitative Analysis of 1H NMR Metabolomics Data
  publication-title: Anal. Chem.
  doi: 10.1021/ac060209g
  contributor:
    fullname: Weljie
– volume: 7
  start-page: 201
  year: 2001
  ident: ref_1
  article-title: Clinical Application of Pharmacogenetics
  publication-title: Trends Mol. Med.
  doi: 10.1016/S1471-4914(01)01986-4
  contributor:
    fullname: Spear
– volume: 6
  start-page: 125
  year: 2011
  ident: ref_113
  article-title: Common Toxicities of Mammalian Target of Rapamycin Inhibitors
  publication-title: Target. Oncol.
  doi: 10.1007/s11523-011-0174-9
  contributor:
    fullname: Soefje
– volume: 78
  start-page: 2262
  year: 2006
  ident: ref_83
  article-title: Scaling and Normalization Effects in NMR Spectroscopic Metabonomic Data Sets
  publication-title: Anal. Chem.
  doi: 10.1021/ac0519312
  contributor:
    fullname: Craig
– volume: 38
  start-page: 436
  year: 2015
  ident: ref_118
  article-title: Effects of Histidine and N-Acetylcysteine on Experimental Lesions Induced by Doxorubicin in Sciatic Nerve of Rats
  publication-title: Drug Chem. Toxicol.
  doi: 10.3109/01480545.2014.981753
  contributor:
    fullname: Farshid
– volume: 5
  start-page: 81
  year: 2020
  ident: ref_40
  article-title: Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Metabolomics
  publication-title: Kidney Int. Rep.
  doi: 10.1016/j.ekir.2019.09.010
  contributor:
    fullname: Gooding
– volume: 23
  start-page: 1422
  year: 2017
  ident: ref_109
  article-title: Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-16-1153
  contributor:
    fullname: Hart
– volume: 440
  start-page: 1073
  year: 2006
  ident: ref_14
  article-title: Pharmaco-Metabonomic Phenotyping and Personalized Drug Treatment
  publication-title: Nature
  doi: 10.1038/nature04648
  contributor:
    fullname: Lindon
– volume: 41
  start-page: D801
  year: 2013
  ident: ref_85
  article-title: HMDB 3
  publication-title: 0—The Human Metabolome Database in Nucleic Acids Res.
  doi: 10.1093/nar/gks1065
  contributor:
    fullname: Wishart
– volume: 146
  start-page: 135
  year: 2017
  ident: ref_70
  article-title: 1H NMR Based Pharmacometabolomics Analysis of Urine Identifies Metabolic Phenotype of Clopidogrel High on Treatment Platelets Reactivity in Coronary Artery Disease Patients
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2017.08.018
  contributor:
    fullname: Amin
– volume: 63
  start-page: 754
  year: 1997
  ident: ref_119
  article-title: Decreased Beta -Phenylethylamine in CSF in Parkinson’s Disease
  publication-title: J. Neurol. Neurosurg. Psychiatry
  doi: 10.1136/jnnp.63.6.754
  contributor:
    fullname: Zhou
– volume: 14
  start-page: 156
  year: 2018
  ident: ref_26
  article-title: Insights into Gemcitabine Resistance and the Potential for Therapeutic Monitoring
  publication-title: Metabolomics
  doi: 10.1007/s11306-018-1452-7
  contributor:
    fullname: Gebregiworgis
– volume: 20
  start-page: 169
  year: 2020
  ident: ref_78
  article-title: Plasma Metabolites as Predictors of Warfarin Outcome in Atrial Fibrillation
  publication-title: Am. J. Cardiovasc. Drugs
  doi: 10.1007/s40256-019-00364-2
  contributor:
    fullname: Bawadikji
– ident: ref_102
  doi: 10.1186/s12885-021-08137-4
– ident: ref_106
– volume: 134
  start-page: 2572
  year: 2014
  ident: ref_122
  article-title: Myo-Inositol Trispyrophosphate-Mediated Hypoxia Reversion Controls Pancreatic Cancer in Rodents and Enhances Gemcitabine Efficacy
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.28597
  contributor:
    fullname: Raykov
– volume: 112
  start-page: 275
  year: 1995
  ident: ref_57
  article-title: Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients
  publication-title: J. Magn. Reson. Ser. A
  doi: 10.1006/jmra.1995.1047
  contributor:
    fullname: Hwang
– volume: 98
  start-page: 71
  year: 2015
  ident: ref_17
  article-title: Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine
  publication-title: Clin. Pharmacol. Ther.
  doi: 10.1002/cpt.134
  contributor:
    fullname: Weinshilboum
– volume: 97
  start-page: 208
  year: 2019
  ident: ref_27
  article-title: Effect of Non-Surgical Periodontal Therapy on Salivary Metabolic Fingerprint of Generalized Chronic Periodontitis Using Nuclear Magnetic Resonance Spectroscopy
  publication-title: Arch. Oral Biol.
  doi: 10.1016/j.archoralbio.2018.10.023
  contributor:
    fullname: Romano
– volume: 22
  start-page: 1154
  year: 2006
  ident: ref_103
  article-title: GALGO: An R Package for Multivariate Variable Selection Using Genetic Algorithms
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btl074
  contributor:
    fullname: Trevino
– volume: 403
  start-page: 1523
  year: 2012
  ident: ref_124
  article-title: Current Trends and Challenges in Sample Preparation for Global Metabolomics Using Liquid Chromatography–Mass Spectrometry
  publication-title: Anal. Bioanal. Chem.
  doi: 10.1007/s00216-012-6039-y
  contributor:
    fullname: Vuckovic
– ident: ref_33
– volume: 4
  start-page: 3361
  year: 2019
  ident: ref_90
  article-title: InterSpin: Integrated Supportive Webtools for Low- and High-Field NMR Analyses Toward Molecular Complexity
  publication-title: ACS Omega
  doi: 10.1021/acsomega.8b02714
  contributor:
    fullname: Yamada
– volume: 15
  start-page: 1446
  year: 2016
  ident: ref_77
  article-title: Sequential Serum Metabolomic Profiling after Radiofrequency Ablation of Hepatocellular Carcinoma Reveals Different Response Patterns According to Etiology
  publication-title: J. Proteome Res.
  doi: 10.1021/acs.jproteome.5b01032
  contributor:
    fullname: Goossens
– volume: 43
  start-page: W251
  year: 2015
  ident: ref_104
  article-title: MetaboAnalyst 3.0—Making Metabolomics More Meaningful
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv380
  contributor:
    fullname: Xia
– volume: 273
  start-page: 28
  year: 2018
  ident: ref_47
  article-title: Circulating Metabolomic Profile Can Predict Dyslipidemia in HIV Patients Undergoing Antiretroviral Therapy
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2018.04.008
  contributor:
    fullname: Domingo
– volume: 171
  start-page: 657
  year: 2018
  ident: ref_94
  article-title: Pharmacometabolomics Reveals a Role for Histidine, Phenylalanine, and Threonine in the Development of Paclitaxel-Induced Peripheral Neuropathy
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-018-4862-3
  contributor:
    fullname: Sun
– volume: 17
  start-page: 451
  year: 2016
  ident: ref_30
  article-title: Metabolomics: Beyond Biomarkers and towards Mechanisms
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm.2016.25
  contributor:
    fullname: Johnson
– volume: 12
  start-page: 3511
  year: 2017
  ident: ref_73
  article-title: Metabolic Changes of Different High-Resolution Computed Tomography Phenotypes of COPD after Budesonide-Formoterol Treatment
  publication-title: Int. J. Chronic Obstruct. Pulmon. Dis.
  doi: 10.2147/COPD.S152134
  contributor:
    fullname: Wang
– volume: 55
  start-page: 679
  year: 2011
  ident: ref_67
  article-title: Biochemical and Metabolomic Phenotyping in the Identification of a Vitamin D Responsive Metabotype for Markers of the Metabolic Syndrome
  publication-title: Mol. Nutr. Food Res.
  doi: 10.1002/mnfr.201000458
  contributor:
    fullname: Gibney
– volume: 73
  start-page: 931
  year: 2021
  ident: ref_34
  article-title: The Pretreatment Gut Microbiome Is Associated with Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis
  publication-title: Arthritis Rheumatol.
  doi: 10.1002/art.41622
  contributor:
    fullname: Artacho
– ident: ref_7
  doi: 10.1371/journal.pcbi.1002817
– volume: 3
  start-page: 361
  year: 2003
  ident: ref_11
  article-title: Pharmacogenomics and “Individualized Drug Therapy”: High Expectations and Disappointing Achievements
  publication-title: Am. J. Pharm.
  contributor:
    fullname: Nebert
– volume: 3
  start-page: 149
  year: 2003
  ident: ref_12
  article-title: Prospects and Limits of Pharmacogenetics: The Thiopurine Methyl Transferase (TPMT) Experience
  publication-title: Am. J. Pharm.
  contributor:
    fullname: Schmedders
– volume: 25
  start-page: 417
  year: 2012
  ident: ref_9
  article-title: Clinical Application of Pharmacogenomics
  publication-title: J. Pharm. Pract.
  doi: 10.1177/0897190012448309
  contributor:
    fullname: Ma
– volume: 44
  start-page: D463
  year: 2016
  ident: ref_95
  article-title: Metabolomics Workbench: An International Repository for Metabolomics Data and Metadata, Metabolite Standards, Protocols, Tutorials and Training, and Analysis Tools
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv1042
  contributor:
    fullname: Sud
– volume: 12
  start-page: 46
  year: 2015
  ident: ref_38
  article-title: Pharmacometabolomics of L-Carnitine Treatment Response Phenotypes in Patients with Septic Shock
  publication-title: Ann. Am. Thorac. Soc.
  doi: 10.1513/AnnalsATS.201409-415OC
  contributor:
    fullname: Puskarich
– volume: 38
  start-page: 545
  year: 2013
  ident: ref_8
  article-title: Role of Pharmacogenomic Biomarkers in Predicting and Improving Drug Response: Part 1: The Clinical Significance of Pharmacogenetic Variants
  publication-title: Pharm. Ther.
  contributor:
    fullname: Ventola
– volume: 18
  start-page: 49
  year: 2020
  ident: ref_23
  article-title: Gut Metabolomics Profiling of Non-Small Cell Lung Cancer (NSCLC) Patients under Immunotherapy Treatment
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-020-02231-0
  contributor:
    fullname: Botticelli
– volume: 9
  start-page: 2041
  year: 2019
  ident: ref_75
  article-title: Reflection of Treatment Proficiency of Hydroxyurea Treated β-Thalassemia Serum Samples through Nuclear Magnetic Resonance Based Metabonomics
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-38823-0
  contributor:
    fullname: Khalid
– volume: 48
  start-page: D440
  year: 2020
  ident: ref_91
  article-title: MetaboLights: A Resource Evolving in Response to the Needs of Its Scientific Community
  publication-title: Nucleic Acids Res.
  contributor:
    fullname: Haug
– ident: ref_63
  doi: 10.20944/preprints202101.0521.v1
– volume: 122
  start-page: 93
  year: 2013
  ident: ref_65
  article-title: Optimized Bucketing for NMR Spectra: Three Case Studies
  publication-title: Chemom. Intell. Lab. Syst.
  doi: 10.1016/j.chemolab.2013.01.006
  contributor:
    fullname: Sousa
– volume: 65
  start-page: 1448
  year: 2013
  ident: ref_42
  article-title: Metabolic Profiling Predicts Response to Anti-Tumor Necrosis Factor α Therapy in Patients with Rheumatoid Arthritis
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.37921
  contributor:
    fullname: Kapoor
– volume: 123
  start-page: 1661
  year: 2011
  ident: ref_6
  article-title: Pharmacogenomics: The Genetics of Variable Drug Responses
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.914820
  contributor:
    fullname: Roden
– volume: 9
  start-page: 1428
  year: 2020
  ident: ref_76
  article-title: Chemotherapeutic Efficacy of Cucurmosin for Pancreatic Cancer as an Alternative of Gemcitabine: A Comparative Metabolomic Study
  publication-title: Gland Surg.
  doi: 10.21037/gs-20-202
  contributor:
    fullname: Wei
– volume: 29
  start-page: 688
  year: 1958
  ident: ref_54
  article-title: Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
  publication-title: Rev. Sci. Instrum.
  doi: 10.1063/1.1716296
  contributor:
    fullname: Meiboom
– volume: 117
  start-page: 351
  year: 2018
  ident: ref_74
  article-title: Pharmacometabolomics Analysis of Plasma to Phenotype Clopidogrel High on Treatment Platelets Reactivity in Coronary Artery Disease Patients
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/j.ejps.2018.03.011
  contributor:
    fullname: Amin
– volume: 11
  start-page: 241
  year: 2010
  ident: ref_5
  article-title: Genome-Wide Association Studies in Pharmacogenomics
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg2751
  contributor:
    fullname: Daly
– volume: 352
  start-page: 2211
  year: 2005
  ident: ref_3
  article-title: Drug Metabolism and Variability among Patients in Drug Response
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra032424
  contributor:
    fullname: Wilkinson
– volume: 132
  start-page: 103
  year: 2017
  ident: ref_98
  article-title: Metabolomic Profiling of Doxycycline Treatment in Chronic Obstructive Pulmonary Disease
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2016.09.034
  contributor:
    fullname: Singh
– volume: 17
  start-page: 4017
  year: 2018
  ident: ref_61
  article-title: Combining Mass Spectrometry and NMR Improves Metabolite Detection and Annotation
  publication-title: J. Proteome Res.
  doi: 10.1021/acs.jproteome.8b00567
  contributor:
    fullname: Bhinderwala
– volume: 22
  start-page: 5575
  year: 2002
  ident: ref_112
  article-title: The Immunosuppressant Rapamycin Mimics a Starvation-like Signal Distinct from Amino Acid and Glucose Deprivation
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.22.15.5575-5584.2002
  contributor:
    fullname: Peng
– volume: 32
  start-page: 565
  year: 2018
  ident: ref_45
  article-title: A Baseline Metabolomic Signature Is Associated with Immunological CD4+ T-Cell Recovery after 36 Months of Antiretroviral Therapy in HIV-Infected Patients
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000001730
  contributor:
    fullname: Pacheco
– volume: 85
  start-page: 11326
  year: 2013
  ident: ref_79
  article-title: Pattern Recognition Analysis for Hepatotoxicity Induced by Acetaminophen Using Plasma and Urinary 1H NMR-Based Metabolomics in Humans
  publication-title: Anal. Chem.
  doi: 10.1021/ac402390q
  contributor:
    fullname: Kim
– volume: 3
  start-page: e125
  year: 2014
  ident: ref_16
  article-title: Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability
  publication-title: CPT Pharmacomet. Syst. Pharmacol.
  contributor:
    fullname: Lewis
– volume: 15
  start-page: 110
  year: 2019
  ident: ref_101
  article-title: NMR-Based Metabolomics in Real-Time Monitoring of Treatment Induced Toxicity and Cachexia in Head and Neck Cancer: A Method for Early Detection of High Risk Patients
  publication-title: Metabolomics
  doi: 10.1007/s11306-019-1576-4
  contributor:
    fullname: Boguszewicz
– volume: 30
  start-page: 1685
  year: 2011
  ident: ref_126
  article-title: Data-Processing Strategies for Metabolomics Studies
  publication-title: Trends Anal. Chem.
  doi: 10.1016/j.trac.2011.04.019
  contributor:
    fullname: Hendriks
– volume: 7
  start-page: 297
  year: 2013
  ident: ref_41
  article-title: Metabolomics Approach for Predicting Response to Neoadjuvant Chemotherapy for Breast Cancer
  publication-title: Mol. Oncol.
  doi: 10.1016/j.molonc.2012.10.003
  contributor:
    fullname: Wei
– volume: 67
  start-page: 793
  year: 1995
  ident: ref_55
  article-title: 750 MHz 1H and 1H-13C NMR Spectroscopy of Human Blood Plasma
  publication-title: Anal. Chem.
  doi: 10.1021/ac00101a004
  contributor:
    fullname: Nicholson
– volume: 10
  start-page: 1107
  year: 2019
  ident: ref_49
  article-title: Metabolomic Analysis of Platelets of Patients with Aspirin Non-Response
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2019.01107
  contributor:
    fullname: Chiang
– ident: ref_52
  doi: 10.3390/cancers12123574
– volume: 49
  start-page: 1955
  year: 2017
  ident: ref_28
  article-title: Metabolite Signatures of Doxorubicin Induced Toxicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
  publication-title: Amino Acids
  doi: 10.1007/s00726-017-2419-0
  contributor:
    fullname: Chaudhari
– volume: 13
  start-page: 36
  year: 2017
  ident: ref_64
  article-title: NMRProcFlow: A Graphical and Interactive Tool Dedicated to 1D Spectra Processing for NMR-Based Metabolomics
  publication-title: Metabolomics
  doi: 10.1007/s11306-017-1178-y
  contributor:
    fullname: Jacob
– volume: 14
  start-page: 31
  year: 2018
  ident: ref_82
  article-title: Recommended Strategies for Spectral Processing and Post-Processing of 1D 1H-NMR Data of Biofluids with a Particular Focus on Urine
  publication-title: Metabolomics
  doi: 10.1007/s11306-018-1321-4
  contributor:
    fullname: Emwas
– volume: 52
  start-page: 345
  year: 2001
  ident: ref_4
  article-title: Pharmacogenetics and Pharmacogenomics
  publication-title: Br. J. Clin. Pharmacol.
  doi: 10.1046/j.0306-5251.2001.01498.x
  contributor:
    fullname: Pirmohamed
– volume: 10
  start-page: e001564
  year: 2017
  ident: ref_107
  article-title: Effect of Metformin on Metabolites and Relation with Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction
  publication-title: Circ. Cardiovasc. Genet.
  doi: 10.1161/CIRCGENETICS.116.001564
  contributor:
    fullname: Eppinga
– volume: 9
  start-page: 216
  year: 2016
  ident: ref_100
  article-title: A Pilot Metabolic Profiling Study of Patients with Neonatal Jaundice and Response to Phototherapy
  publication-title: Clin. Transl. Sci.
  doi: 10.1111/cts.12401
  contributor:
    fullname: Cai
– volume: 44
  start-page: 900
  year: 1998
  ident: ref_121
  article-title: Effect of Increasing Dietary Threonine Intakes on Amino Acid Metabolism of the Central Nervous System and Peripheral Tissues in Growing Rats
  publication-title: Pediatr. Res.
  doi: 10.1203/00006450-199812000-00013
  contributor:
    fullname: Boehm
– volume: 4
  start-page: 165
  year: 2012
  ident: ref_71
  article-title: (1)H NMR-Based Metabolomic Analysis for Identifying Serum Biomarkers to Evaluate Methotrexate Treatment in Patients with Early Rheumatoid Arthritis
  publication-title: Exp. Ther. Med.
  doi: 10.3892/etm.2012.567
  contributor:
    fullname: Wang
– volume: 17
  start-page: 91
  year: 2007
  ident: ref_120
  article-title: Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU
  publication-title: Neuropsychol. Rev.
  doi: 10.1007/s11065-007-9021-2
  contributor:
    fullname: Moyle
– volume: 348
  start-page: 577385
  year: 2020
  ident: ref_69
  article-title: 12-Months Prospective Pentraxin-3 and Metabolomic Evaluation in Multiple Sclerosis Patients Treated with Glatiramer Acetate
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2020.577385
  contributor:
    fullname: Signoriello
– volume: 310
  start-page: 943
  year: 2003
  ident: ref_59
  article-title: Improved Methods for the Acquisition and Interpretation of NMR Metabolomic Data
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2003.09.092
  contributor:
    fullname: Viant
– volume: 490
  start-page: 3
  year: 2003
  ident: ref_97
  article-title: NMR-Based Metabonomic Toxicity Classification: Hierarchical Cluster Analysis and k-Nearest-Neighbour Approaches
  publication-title: Anal. Chim. Acta
  doi: 10.1016/S0003-2670(03)00060-6
  contributor:
    fullname: Beckonert
– volume: 29
  start-page: 261
  year: 2013
  ident: ref_117
  article-title: Effects of Histamine on Spontaneous Neuropathic Pain Induced by Peripheral Axotomy
  publication-title: Neurosci. Bull.
  doi: 10.1007/s12264-013-1316-0
  contributor:
    fullname: Yu
– volume: 3
  start-page: 38
  year: 2015
  ident: ref_93
  article-title: Metabolonote: A Wiki-Based Database for Managing Hierarchical Metadata of Metabolome Analyses
  publication-title: Front. Bioeng. Biotechnol.
  doi: 10.3389/fbioe.2015.00038
  contributor:
    fullname: Ara
– volume: 106
  start-page: 14728
  year: 2009
  ident: ref_18
  article-title: Pharmacometabonomic Identification of a Significant Host-Microbiome Metabolic Interaction Affecting Human Drug Metabolism
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0904489106
  contributor:
    fullname: Clayton
– ident: ref_62
  doi: 10.3390/metabo10050202
– volume: 17
  start-page: 1248
  year: 2018
  ident: ref_46
  article-title: Pharmacometabonomics Analysis Reveals Serum Formate and Acetate Potentially Associated with Varying Response to Gemcitabine-Carboplatin Chemotherapy in Metastatic Breast Cancer Patients
  publication-title: J. Proteome Res.
  doi: 10.1021/acs.jproteome.7b00859
  contributor:
    fullname: Jiang
– volume: 14
  start-page: 242
  year: 2013
  ident: ref_110
  article-title: The Multifaceted Role of MTORC1 in the Control of Lipid Metabolism
  publication-title: EMBO Rep.
  doi: 10.1038/embor.2013.5
  contributor:
    fullname: Ricoult
– volume: 2
  start-page: 2692
  year: 2007
  ident: ref_31
  article-title: Metabolic Profiling, Metabolomic and Metabonomic Procedures for NMR Spectroscopy of Urine, Plasma, Serum and Tissue Extracts
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2007.376
  contributor:
    fullname: Beckonert
– volume: 28
  start-page: 126
  year: 2014
  ident: ref_114
  article-title: Strategies for the Management of Adverse Events Associated with MTOR Inhibitors
  publication-title: Transplant. Rev.
  doi: 10.1016/j.trre.2014.03.002
  contributor:
    fullname: Kaplan
– volume: 86
  start-page: 277
  year: 2017
  ident: ref_125
  article-title: Metabolite Measurement: Pitfalls to Avoid and Practices to Follow
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev-biochem-061516-044952
  contributor:
    fullname: Lu
– volume: 39
  start-page: 2308
  year: 2011
  ident: ref_39
  article-title: Metabolic Effects of Albumin Therapy in Acute Lung Injury Measured by Proton Nuclear Magnetic Resonance Spectroscopy of Plasma: A Pilot Study
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0b013e31822571ce
  contributor:
    fullname: Park
– volume: 184
  start-page: 263
  year: 2007
  ident: ref_56
  article-title: SOGGY: Solvent-Optimized Double Gradient Spectroscopy for Water Suppression. A Comparison with Some Existing Techniques
  publication-title: J. Magn. Reson.
  doi: 10.1016/j.jmr.2006.10.014
  contributor:
    fullname: Nguyen
– volume: 19
  start-page: 4770
  year: 2013
  ident: ref_43
  article-title: Multiple Myeloma Patients Have a Specific Serum Metabolomic Profile That Changes after Achieving Complete Remission
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-12-2917
  contributor:
    fullname: Lecumberri
– volume: 32
  start-page: 124
  year: 2007
  ident: ref_116
  article-title: Histaminergic Involvement in Neuropathic Pain Produced by Partial Ligation of the Sciatic Nerve in Rats
  publication-title: Reg. Anesth. Pain Med.
  doi: 10.1016/j.rapm.2006.11.009
  contributor:
    fullname: Huang
– volume: 10
  start-page: 2873
  year: 2011
  ident: ref_25
  article-title: NMR-Based Metabolomic Analysis of the Molecular Pathogenesis of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia
  publication-title: J. Proteome Res.
  doi: 10.1021/pr200200y
  contributor:
    fullname: Cano
– volume: 38
  start-page: 197
  year: 2011
  ident: ref_58
  article-title: How the 1D-NOESY Suppresses Solvent Signal in Metabonomics NMR Spectroscopy: An Examination of the Pulse Sequence Components and Evolution
  publication-title: Concepts Magn. Reson.
  doi: 10.1002/cmr.a.20223
  contributor:
    fullname: Mckay
– volume: 70
  start-page: 1049
  year: 2017
  ident: ref_44
  article-title: Citric Acid Metabolism in Resistant Hypertension: Underlying Mechanisms and Metabolic Prediction of Treatment Response
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.117.09819
  contributor:
    fullname: Martinez
– volume: 26
  start-page: 162
  year: 2008
  ident: ref_86
  article-title: Metabolite Identification via the Madison Metabolomics Consortium Database
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt0208-162
  contributor:
    fullname: Cui
– ident: ref_36
  doi: 10.3390/molecules26092573
– volume: 16
  start-page: 800
  year: 2011
  ident: ref_108
  article-title: Trastuzumab
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2010-0035
  contributor:
    fullname: Boekhout
– ident: ref_72
  doi: 10.1371/journal.pone.0138537
– volume: 18
  start-page: 3649
  year: 2019
  ident: ref_48
  article-title: Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients
  publication-title: J. Proteome Res.
  doi: 10.1021/acs.jproteome.9b00316
  contributor:
    fullname: Debik
SSID ssj0057141
Score 2.3173091
SecondaryResourceType review_article
Snippet Pharmacometabolomics (PMx) studies aim to predict individual differences in treatment response and in the development of adverse effects associated with...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 1015
SubjectTerms Clinical trials
drug response
Feces
Metabolism
Metabolites
NMR
Nuclear magnetic resonance
personalized medicine
pharmacometabolomics
Systematic Review
Urine
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB1BT1wQUBCBFhkV9dSoieOxs4hLW1r1QqlokbhFHn-olUpasbuH_fcdx_tBTlxQTonnkMzLjN_I42eAT1qR9hGpDBpVqZTCkmTluGoNsnUNkh1kF8-vzMWv9utpkslZH_WVesKyPHB23KEPBjmhYiV9reqgWxsNmYjWOk_W0ZB9K70qpnIORsO2WYy04aL-8OEmtTPyhaPpZ1DpH1HLcWPkXzPN2Qt4vqSI4ii_2kt4EvpXsH-ZNaYXB-J6s2VqeiD2xeVGfXqxDV9Wt7_DjAG-S7uOp4IW4uLbD3Hbi-99tvwsjsTVWsZZ5DWC1_Dz7PT65LxcHpFQOqUms9K3jgmVQ6pdw1zFoquiwdioKlqXtOSQ46tl1hLIR92a4FUbkgKqbqMmDsA3sNXf9-EtCKSGwSGnLUlFhiax8kGHoGrSyqEuYG_lue4hK2F0XEEk_3Yb_xZwnJy6tkjq1cMDxrRbYtr9C9MCdlaQdMuQmnaSqZLSKCtZwMf1MAdDWuGwfbifZxvDKcXUBZgRlKMXGo_0tzeDrDYTl4lE-e5_fMF7eCZT80vqNJA7sDX7Mw-78HTq5x-GH_UR7CDxBw
  priority: 102
  providerName: Directory of Open Access Journals
Title Pharmacometabolomics by NMR in Oncology: A Systematic Review
URI https://www.proquest.com/docview/2584465202
https://search.proquest.com/docview/2584796371
https://pubmed.ncbi.nlm.nih.gov/PMC8539252
https://doaj.org/article/de75678502d141e68af7b7f5aacdbacb
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b9swED7UmboUbZqiatOARYJMUSxRfMhBlzQPZElqNCnQTeCRVGIglo3YHvzve9TDjtZCk0QSEO54vO_Ajx8BjpRA5UqJsVdSxEIIGSNPLFWtnuc2k2hq2cWbe333N7-8CjI5sjsLU5P2LU5Oq-fpaTV5qrmV86kddjyx4fj2glLMiEs-HMCAsGFXojfLr9SpSBsd0ozq-eH8KTAZ6Ql31GQiyG2Fi8FfJaFaq78HMPv0yFf55vo9vGuBIjtvfugDvPHVLhyPG6Xp9Ql72B6cWpywYzbealCvP8KP7nXql-Tm53D2eMFwze5uf7NJxX5VTc8zds7uN2LOrNkp2IM_11cPFzdxe1FCbIUYLWOXW4JVVmJqM0IsRtqk1LLMRFIaGxTlJEVZTtjFoytVrr0TuQ86qCovFVIYfoKdalb5z8AkZuQitMogF6hxVCbOK-9FikpYqSI47CxXzBs9jILqiGDqYmvqCH4Go256BA3r-sPs5bFoPVk4ryWlSplwR-O8yk2pUZfSGOvQWIxgv3NJ0QbWouAEmISSPOERfN80U0iEfQ5T-dmq6aNpYdFpBLrnyt4P9VtortXi2u3c-vLfI7_CWx54L4FkwPdhZ_my8t9gsHCrg7rgP6in6z_6xPDq
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB7RcoALb9SFAkagnrrNrtePDeJSSqsgmhDRIHFb-UkjNZuoSQ7594z3kXSv1Z68tiXLn8czI3_-DPBZMC2s5zp2grOYMcZjTRODWaujucm4VpXs4uBKjv7m38-DTA5v78JUpH2jpyflzeyknF5X3MrFzPRanlhvPDxDF9OnnPb24CHaa5K0SXq9AXOZsrRWIs0wo-8trgOXEb_wSk3GguBWeBr8jhuq1Po7IWaXIHnH41w8vedYn8GTJsQkp3X1c3jgyhdwNK41qjfHZLK7crU8JkdkvFOv3ryEr21x5la4QG7CreUl0RsyGv4m05L8KuuWX8gpudrKQJP6jOEV_Lk4n5wN4uaJhdgw1l_FNjcYkBmuU5NhrKO4SbzkPmOJVyZo0XG0zxyjHqetF7l0luUuKKiK3AuNBvwa9st56Q6AcJ0huNoIpSnTUvd9Yp1wjqVaMMNFBJ_aGS8WtZJGgRlIgKjYQRTBtwDGtkVQv65-zG__Fc28FtZJjk6WJ9RiPydy5aWWnitlrFZGR3DYQlk0JrksKIZaTHCa0Ag-bqvRmMIJiSrdfF23kbglyTQC2VkCnQF1axD5Spa7QfrNvXt-gEeDyfCyuPwx-vkWHtPAnglUBXoI-6vbtXsHe0u7fl8t9v9xygWO
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxEB7RIiEuvFEXChiBeup2d71-bBCX0jYqgoaIFonbyk8aqdlETXLIv2e8j6R7Be3J67FkeTyeGfnzNwAfBdPCeq5jJziLGWM81jQ1mLU6Wpica1XTLp5fytHv4vQs0ORsSn3VoH2jJ0fVzfSomlzX2Mr51CQdTiwZX5ygixlQTpO59ckO3EebTWmXqDeHMJcZyxo20hyz-mR-HfCM-IVKNTkLpFuhPPgdV1Qz9vfCzD5I8o7XGT7-j_k-gUdtqEmOG5GncM9Vz-Bg3HBVrw_J1fbp1eKQHJDxlsV6_Rw-d82pW-JGuQmvlxdEr8no4ieZVORH1Uh-IsfkckMHTZq7hhfwa3h2dXIet6UWYsPYYBnbwmBgZrjOTI4xj-Im9ZL7nKVemcBJx9FOC4x-nLZeFNJZVrjApCoKLzQa8kvYrWaV2wPCdY5K1kYoTZmWeuBT64RzLNOCGS4i-NCtejlvGDVKzESCmsqtmiL4EhSykQgs2PWP2e2fsl3b0jrJ0dnylFoc50ShvNTSc6WM1croCPY7dZataS5KiiEXE5ymNIL3m240qnBToio3WzUyEo8mmUUge9ugN6F-D2q_pudutf3qn0e-gwfj02H5_evo22t4SAOIJiAW6D7sLm9X7g3sLOzqbb3f_wKl8AgO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacometabolomics+by+NMR+in+Oncology%3A+A+Systematic+Review&rft.jtitle=Pharmaceuticals+%28Basel%2C+Switzerland%29&rft.au=G%C3%B3mez-Cebri%C3%A1n%2C+Nuria&rft.au=Pedro+V%C3%A1zquez+Ferreiro&rft.au=Carrera+Hueso%2C+Francisco+Javier&rft.au=Poveda+Andr%C3%A9s%2C+Jos%C3%A9+Luis&rft.date=2021-10-02&rft.pub=MDPI+AG&rft.eissn=1424-8247&rft.volume=14&rft.issue=10&rft.spage=1015&rft_id=info:doi/10.3390%2Fph14101015&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1424-8247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1424-8247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1424-8247&client=summon